| The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ... Hepatology 67 (1), 328-357, 2018 | 7283 | 2018 |
| Mechanisms of NAFLD development and therapeutic strategies SL Friedman, BA Neuschwander-Tetri, M Rinella, AJ Sanyal Nature medicine 24 (7), 908-922, 2018 | 3760 | 2018 |
| MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020 | 3054 | 2020 |
| A multi-society Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Annals of Hepatology, 101133, 2023 | 3013 | 2023 |
| Nonalcoholic fatty liver disease: a systematic review ME Rinella Jama 313 (22), 2263-2273, 2015 | 2767 | 2015 |
| Non-alcoholic fatty liver disease EE Powell, VWS Wong, M Rinella The Lancet 397 (10290), 2212-2224, 2021 | 2070 | 2021 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1215 | 2019 |
| AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease ME Rinella, BA Neuschwander-Tetri, MS Siddiqui, MF Abdelmalek, ... Hepatology 77 (5), 1797-1835, 2023 | 1185 | 2023 |
| Nonalcoholic fatty liver disease 2020: the state of the disease TG Cotter, M Rinella Gastroenterology 158 (7), 1851-1864, 2020 | 1125 | 2020 |
| Nonalcoholic fatty liver disease EM Brunt, VWS Wong, V Nobili, CP Day, S Sookoian, JJ Maher, ... Nature reviews Disease primers 1 (1), 1-22, 2015 | 920 | 2015 |
| American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and … K Cusi, S Isaacs, D Barb, R Basu, S Caprio, WT Garvey, S Kashyap, ... Endocrine Practice 28 (5), 528-562, 2022 | 755 | 2022 |
| A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis SA Harrison, P Bedossa, CD Guy, JM Schattenberg, R Loomba, R Taub, ... New England Journal of Medicine 390 (6), 497-509, 2024 | 623 | 2024 |
| Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022 | 592 | 2022 |
| The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance ME Rinella, RM Green Journal of hepatology 40 (1), 47-51, 2004 | 548 | 2004 |
| Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet ME Rinella, MS Elias, RR Smolak, T Fu, J Borensztajn, RM Green Journal of lipid research 49 (5), 1068-1076, 2008 | 547 | 2008 |
| Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis ZM Younossi, R Loomba, QM Anstee, ME Rinella, E Bugianesi, ... Hepatology 68 (1), 349-360, 2018 | 477 | 2018 |
| NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial SA Harrison, ME Rinella, MF Abdelmalek, JF Trotter, AH Paredes, ... The Lancet 391 (10126), 1174-1185, 2018 | 453 | 2018 |
| Management of NAFLD: a stage-based approach ME Rinella, AJ Sanyal Nature reviews Gastroenterology & hepatology 13 (4), 196-205, 2016 | 453 | 2016 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 408 | 2020 |
| Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ZM Younossi, R Loomba, ME Rinella, E Bugianesi, G Marchesini, ... Hepatology 68 (1), 361-371, 2018 | 408 | 2018 |